Advertisement
Research paper| Volume 75, ISSUE 2-3, P183-188, February 1989

Lack of correlation between the apolipoprotein B Xba I polymorphism and blood lipid levels in a Swedish population

DOI:https://doi.org/10.1016/0021-9150(89)90175-5
Lack of correlation between the apolipoprotein B Xba I polymorphism and blood lipid levels in a Swedish population
Previous ArticleEffects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes
Next ArticleHigh density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The possible connections between the apolipoprotein B (apo B) XbaI polymorphism and the serum levels of total cholesterol, triglycerides, LDL, HDL and apo B have been investigated among 187 randomly selected subjects from Gothenburg, Sweden. The interferences of age and sex on the serum lipoproteins and apo B concentrations were considered. Using multiple regression analysis, we compared the different lipid levels and the levels of apo B with the genotypes X1X1 X1X2 and X2X2 (X1 = without the XbaI restriction site, X2 = with the site), with age and with sex and with those factors combined with each other. A significantly higher concentration of serum cholesterol and LDL among men than among women was found and total serum cholesterol, LDL and apo B were positively correlated with age. The allele frequency of the XbaI polymorphism in the sample was 0.45 for the allele without the XbaI restriction site. No correlation was found between the apo B genotypes and the levels of serum lipoproteins or apo B.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Brunzell J.D.
        • Sniderman A.D.
        • Albers J.J.
        • Kwiterovitch P.O.
        Apolipoproteins B and A–I and coronary artery disease in humans.
        Arteriosclerosis,. 1984; 4: 79
        • Avogaro P.
        • Bon G.B.
        • Cazzolato G.
        • Quinci G.B.
        • Belussi F.
        Plasma levels of apolipoprotein AI and apolipoprotein B in human atherosclerosis.
        Artery. 1978; 4: 385
        • Sniderman A.
        • Shapiro S.
        • Marpole D.
        • Skinner B.
        • Terg B.
        • Kwiterovich Jr., P.O.
        Association of coronary atherosclerosis with hyperapobetalipoproteinaemia (increased protein but normal cholesterol levels in human plasma low density lipoproteins).
        in: 2nd edn. Proc. Natl. Acad. Sci. USA. 77. 1981: 604
        • Durrington P.N.
        • Hunt L.
        • Ishola M.
        • Kane J.
        • Stephens W.P.
        Serum apolipoprotein AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.
        Br. Heart J. 1986; 56: 206
        • Fager G.
        • Wiklund O.
        • Olofsson S.-O.
        • Wilhelmsen L.
        • Bondjers G.
        Multivariate analysis of serum apolipoproteins and risk factors in relation to acute myocardial infarction.
        Arteriosclerosis. 1981; 1: 273
        • Berg K.
        • Harries C.
        • Dahlén G.
        • Frick M.H.
        • Kristian L.
        Genetic variation in serum low density lipoproteins and lipid levels in man.
        in: 2nd edn. Proc. Natl. Acad. Sci. USA. 73. 1976: 937
        • Tikkanen M.J.
        • Kvisi T.
        • Yong S.G.
        • Curtiss L.K.
        • Witztum J.L.
        Distribution of apolipoprotein B polymorphic species in normolipidemic Finnish men.
        Arteriosclerosis. 1986; 6: 535
        • Duriez P.
        • Vu Dac N.
        • Koffigan M.
        • Puchois P.
        • Demarquilly C.
        • Fievet C.
        • Fievet P.
        • Luyeye I.
        • Bard J.M.
        • Fourrier J.L.
        • Slimane N.
        • Lablanche J.M.
        • Bertrand M.
        • Fruchart J.C.
        Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosis.
        Atherosclerosis. 1987; 66: 153
        • Priestley L.
        • Knott T.
        • Wallis S.
        • Powell L.
        • Pearse R.
        • Simon A.
        • Scott J.
        RFLP for the human apolipoprotein B gene: V. XbaI.
        Nucleic Acids Res. 1986; 13: 6789
        • Barni N.
        • Talmud P.J.
        • Carlsson P.
        • Azoulay M.
        • Darnfors C.
        • Harding B.
        • Wild D.
        • Grzeeschik K.H.
        • Bjursell G.
        • Junien C.
        • Williamsson R.
        • Hymphries S.E.
        The isolation of genomic recombinants for the human apolipoprotein B gene and the mapping of three common DNA polymorphisms of the gene — a useful marker for the human chromosome 2.
        Hum. Genet. 1986; 73: 313
        • Darnfors C.
        • Nilsson J.
        • Protter A.A.
        • Carlsson P.
        • Talmud P.J.
        • Humphries S.E.
        • Whalström J.
        • Wiklund O.
        • Bjursell G.
        RFLPs for the human apolipoprotein B gene: Hincll and Pvu-II.
        Nucleic Acids Res. 1986; 14: 7135
        • Turturro F.
        • Heibig J.
        • Chan L.
        • Gotto A.M.
        • Ghiselli G.C.
        A complex HindIII, polymorphism in the human apolipoprotein B gene (APOB).
        Nucleic Acids Res. 1987; 15: 9618
        • Jenner K.
        • Sidoli A.
        • Ball M.
        • Rodriquez J.R.
        • Pagani F.
        • Giudici G.
        • Vergani C.
        • Mann J.
        • Baralle F.E.
        • Shoulders C.C.
        Characterization of genetic markers in the 3' end of the apo B gene and their use in family and population studies.
        Atherosclerosis. 1988; 69: 39
        • Law A.
        • Wallis S.C.
        • Powell L.M.
        • Peas R.J.
        • Brunt H.
        • Priesty L.M.
        • Knott T.J.
        • Scott J.
        • Altman D.F.
        • Miller F.J.
        • Rajput J.
        • Miller N.E.
        Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels.
        Lancet. 1986; i: 1301
        • Talmud P.J.
        • Barni N.
        • Kessling A.M.
        • Carlsson P.
        • Darnfors C.
        • Bjursell G.
        • Galton D.
        • Wynn V.
        • Humphries S.E.
        Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels. A study in normo and hypolipidaemic individuals.
        Atherosclerosis. 1987; 67: 81
        • Berg K.
        DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level.
        Clin. Genet. 1986; 30: 515
        • Hegele R.A.
        • Huang Li-S.
        • Herbert P.
        • Blum C.
        • Buring J.E.
        • Henneksen C.H.
        • Breslow J.L.
        Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction.
        New Engl. J. Med. 1986; 315: 1509
        • Wiklund O.
        • Fager G.
        • Graig L.H.
        • Wilhelmsson C.E.
        • Vedin A.
        • Olofsson S.-O.
        • Bondjers G.
        • Wilhelmsen L.
        Alphalipoprotein cholesterol levels in relation to acute myocardial infarction and its risk factors.
        Scand. J. Clin. Invest. 1980; 40: 239
        • Friedewald W.T.
        • Levy R.L.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation.
        Clin. Chem. 1972; 18: 499
        • Kunkel L.M.
        • Smith K.D.
        • Boyer S.H.
        • Borgaonkar D.S.
        • Wachtel S.S.
        • Miller O.J.
        • Breg W.R.
        • Jones Jr., H.W.
        • Rary J.M.
        Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.
        in: 2nd edn. Proc. Natl. Acad. Sci. USA. 74. 1977: 1245
        • Southern E.
        Detection of specific sequences among DNA fragments separated by gel electrophoresis.
        J. Mol. Biol. 1975; 98: 503
        • Carlsson P.
        • Darnfors C.
        • Olofsson S.-O.
        • Bjursell G.
        Analysis of the human apolipoprotein B gene, complete structure of the B-74 region.
        Gene. 1986; 49: 29
        • Feinberg A.P.
        • Vogelstein B.
        A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
        Anal. Biochem. 1983; 132: 6
        • Carlson L.A.
        • Lindstedt S.
        The Stockholm prospective study.
        Acta Med. Scand. (Suppl.). 1968; 493: 1
        • Carlsson L.A.
        • Ericksson M.
        Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies on healthy men and women.
        Atherosclerosis. 1975; 27: 417
      26. 2nd edn. The Lipid Research Clinics Population Studies Data Book, Vol. 1. The Prevalence Study. Government Printing, 1980 (NIH Publication No. 80–1527)
        • Berg K.
        • Powell L.M.
        • Wallis S.C.
        • Pease R.
        • Knott T.J.
        • Scott J.
        Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus.
        in: 2nd edn. Proc. Natl. Acad. Sci. USA. 83. 1986: 7367
        • Berg K.
        Assignment of the locus for the AGX allotypes of human LDL.
        Cytogenet. Cell Genet. HGM9. 1987; 46: 579
        • Tikkanen M.J.
        • Ehnholm C.
        • Kowanen P.T.
        • Butler R.
        • Yong S.G.
        • Curtiss L.K.
        • Witztum J.L.
        Detection of apolipoprotein B species (apoBc and apoBg) by a monoclonal antibody.
        Atherosclerosis. 1987; 65: 247

      Article info

      Publication history

      Accepted: October 14, 1988
      Received in revised form: October 13, 1988
      Received: June 20, 1988

      Identification

      DOI: https://doi.org/10.1016/0021-9150(89)90175-5

      Copyright

      © 1989 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX